On a recent episode of VITAL HEALTH podcast, NPC President and CEO John M. O’Brien spoke with Duane Schultness, managing director of Vital Transformation, about various policy proposals and their potential impact on outcomes and spending and, ultimately, patient access to biopharmaceutical innovation.